Literature DB >> 1500396

Pulse wave mechanics revisited: relevance to therapy of cardiovascular disease with calcium antagonists.

M F O'Rourke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1500396     DOI： 10.1007/bf01744864

Source DB:  PubMed          Journal:  Heart Vessels        ISSN： 0910-8327            Impact factor:   2.037


× No keyword cloud information.
  48 in total

1.  Coronary vasodilation with dihydropyridines--a pharmacokinetic study.

Authors:  S Jost; W Rafflenbeul; B Mogwitz; U Nellessen; C Bossaller; P Zwicky; H Hecker; P Lippolt; P R Lichtlen
Journal:  Eur Heart J       Date:  1989-11       Impact factor: 29.983

2.  Calcium antagonist caution.

Authors: 
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

3.  Toward a more complete understanding of left ventricular afterload.

Authors:  R B Devereux
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

4.  Calcium channel blockers and congestive heart failure.

Authors:  G S Francis
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

5.  Interaction of left ventricular contraction and aortic input impedance in experimental and clinical studies.

Authors:  T Yaginuma; T Noda; M Tsuchiya; K Takazawa; H Tanaka; K Kotoda; S Hosoda
Journal:  Jpn Circ J       Date:  1985-02

6.  Triple control of relaxation: implications in cardiac disease.

Authors:  D L Brutsaert; F E Rademakers; S U Sys
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

7.  Steady and pulsatile energy losses in the systemic circulation under normal conditions and in simulated arterial disease.

Authors:  M F O'Rourke
Journal:  Cardiovasc Res       Date:  1967-10       Impact factor: 10.787

8.  Role of calcium antagonists in systemic hypertension.

Authors:  A Zanchetti
Journal:  Am J Cardiol       Date:  1987-01-30       Impact factor: 2.778

9.  Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; J W Deckers
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

Review 10.  The effect of dihydropyridine calcium antagonists in hypertensive patients with impaired renal function.

Authors:  L H Hansson
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105
View more
  2 in total

1.  Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.

Authors:  K Breithaupt-Grögler; M Leschinger; G G Belz; R Butzer; K Erb; C de May; W Sinn
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

Review 2.  Elastic properties and Windkessel function of the human aorta.

Authors:  G G Belz
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.